CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Grant or award Director acquired 13,513 shares (grant or award)
- 8-K Event Regulation FD disclosure
- 4/A Open-market buy Director bought 100,000 shares at an average $1.63 ($162,500)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-3/A Offering Registration Statement
- 4 Grant or award 10% owner acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 11,205 shares (grant or award)
- 8-K/A Event Other events
- 8-K Event Other events
Page 23 of 63 · 1,250 filings